Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis- 4-Year Outcomes from the Rapid-Psa Study
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1426
https://www.valueinhealthjournal.com/article/S1098-3015(16)32792-9/fulltext
Title :
Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis- 4-Year Outcomes from the Rapid-Psa Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32792-9&doi=10.1016/j.jval.2016.09.1426
First page :
A594
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1343